Clinical Trial Center LLC Jenkintown, PA - 19046

Clinical Trial Center LLC is categorized under Medical Research in Jenkintown, PA and active since 2001.

Clinical Trial Center LLC was established in 2001, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417115 by the NAICS.

If you are seeking more information, feel free to contact Anita Cummins, President at the company’s single location by writing to 815 Greenwood Avenue # 12, Jenkintown, Pennsylvania PA 19046 or by phoning (215) 884-1700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Clinical Trial Center LLC
Contact Person: Anita Cummins, President
Address: 815 Greenwood Avenue # 12, Jenkintown, Pennsylvania 19046
Phone Number: (215) 884-1700
Website Address: theclinicaltrialcenter.com
Annual Revenue (USD): Unknown
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 5417115
Share This Business:

Clinical Trial Center LLC was started in 2001 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Anita Cummins, President for inquiries that concern Clinical Trial Center LLC by calling the company number (215) 884-1700, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Trial Center LLC can be found at the coordinates 40.094938,-75.124859 as well as the street address 815 Greenwood Avenue # 12 in Jenkintown, Pennsylvania 19046.

For its online presence, you may visit Clinical Trial Center LLC’s website at theclinicaltrialcenter.com and engage with its social media outlets through on Twitter and on Facebook.